Choose a section
Drug maker Bristol-Myers Squibb foresees significant effects on its business from the Patient Protection and Affordable Care Act, company executives told attendees of its recent shareholder meeting.
Japanese drug maker Takeda Pharmaceutical Co. will buy Fort Collins, Colo.-based vaccine maker Inviragen for up to $250 million, the two companies said Wednesday.
There is as much as $10 billion in branded pharmaceutical sales that could make the switch from prescription-only to over-the counter in the next five years, suggested Joseph Papa, Perrigo chairman, CEO and president, to analysts on Tuesday.
The outline of an exam that will be used to certify pharmacists working in the specialty channel has received approval from the Specialty Pharmacy Certification Board, the group said.
The global market for biosimilars will be worth nearly $2.5 billion this year, according to a new study.
Amid rapid growth over the last few years, Amber Pharmacy is more than doubling the size of its headquarters.
Florida's state legislature approved a bill last week that will allow pharmacists to substitute biosimilars for brand name biotech drugs.
Pfizer is attempting to stem the rise of counterfeit medicines by selling one of its most popular drugs — and one of the most popular targets for counterfeiters — online.
Pregnant women should not use migraine-prevention medications containing valproate sodium due to a higher risk of decreased IQ scores in children, the Food and Drug Administration warned.
The Food and Drug Administration has approved a new drug made by Merck for treating high cholesterol, the drug maker said.